Belatacept and Long-Term Outcomes in Kidney Transplantation. - Wikidata - wikimedia - TriplyDB

Belatacept and Long-Term Outcomes in Kidney Transplantation.

Belatacept and Long-Term Outcomes in Kidney Transplantation.

http://www.wikidata.org/entity/Q40055241

about

Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy Unraveling the Role of Allo-Antibodies and Transplant Injury Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation The future direction and unmet needs of transplant immunosuppression.Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.Graft Function and Intermediate-Term Outcomes of Kidney Transplants Improved in the Last Decade: Analysis of the United States Kidney Transplant Database.Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy.Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury Current status of alloimmunity.Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.Costimulation Blockade in Kidney Transplantation: An Update Influence of tacrolimus metabolism rate on renal function after solid organ transplantation.Interruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.Adherence in pediatric kidney transplant recipients: solutions for the system.Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study.Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway.Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.T Cell Cosignaling Molecules in Transplantation.A safety evaluation of belatacept for the treatment of kidney transplant.Should belatacept be the centrepiece of renal transplantation?Unintended Immunological Consequences of Biologic Therapy.The Role of Neutrophils in Transplanted Organs mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?B Cell Immunity in Solid Organ Transplantation.Belatacept Compared to Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.Negative Cardiovascular Consequences of Small Molecule Immunosuppressants.Immune monitoring as prerequisite for transplantation tolerance trials.Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants.Belatacept in renal transplantation-quo vadis?Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.

P2860

Q26745773-474987A6-3DA2-481D-869A-D52C087789F6 Q28069336-699E886F-3266-4350-A4F1-CDFC09BB6426 Q28076193-E6FAFE30-A1D2-4C1A-8E57-8825FA35B91C Q30277037-632C15FF-3DC8-4603-877B-91DDBA02B9FB Q30360800-31E81631-D958-4BC6-9726-84461B1D2AE4 Q33631095-76D75648-54AE-4F03-A75E-022332A226FB Q33779071-BDABEBB6-942D-454F-8447-56603546686E Q33806623-A7920778-2C7E-4F5A-AB83-0E36580B607B Q33874015-746C957B-C894-4FF7-B60F-65473CB6C73B Q34047345-BC782D2F-C185-4D3F-85BF-F0AD769090D1 Q37346073-E5DDA700-96B6-4BBF-9885-338EE53D19A1 Q37375148-0213B87F-5A69-467B-B190-E17D364EA141 Q37662992-8AD0C9D3-5A0B-473A-851B-0AD5E8A2EAEF Q37677433-B6104733-094E-4D4C-92F5-256575DA3079 Q38681685-8ABAD6D5-FD6B-4C8B-8C72-4F94F96D95E3 Q38738778-8720CBAE-82F4-4FF4-A5A6-D5BE3FCA9621 Q38782935-E11176AA-52C5-49F5-A37E-045374D8BB50 Q38786418-C3B4B9A0-B31E-46D0-B8EC-539389D98E8F Q38787174-829D9208-D3BB-441D-9CFE-60E4FBAA3E0A Q38787322-19AC4D6D-B216-4D49-9735-281B89FE5781 Q38804454-995CB3FD-1D40-43BA-A473-41BC3D1AEE8F Q38824724-587BB5A4-092A-4E2F-8F1F-836E5C0DB046 Q38831291-B2A9184E-FDA6-4615-B6FD-496474586375 Q38837473-1B563732-E1B1-4407-8D67-6D9C3DAC457A Q38852360-FB9834E1-B814-4909-922F-0F8D17706D5C Q38862002-8BC60FE2-C318-4F89-9B33-73FF89567D68 Q38871098-8788D2C3-4289-4B83-B79B-CA42EF296F1D Q38876973-7F85E0A7-855C-408C-822C-684464B3F06A Q38962103-F7ADB310-9255-49CE-9B5A-B13B696BE0BE Q39045577-270A45B6-E0A3-4117-B114-44478B797714 Q39101892-BD22668B-9D07-455C-A1BE-C2C70C3E5A0F Q39110742-CC416E05-8DD6-44F9-A85B-66681694EA2D Q39152748-3B3C4597-6F24-4DF9-9114-7B73C4A3F124 Q39161011-578CA1C0-8500-4E17-BE51-CF1F7AEFA5C8 Q39207543-9B05037A-1D6F-4CED-8848-9561CB38D9A5 Q39312540-035DA261-0825-446A-A2BE-95CEF3B89679 Q39314792-FBE69F9F-6EED-4D90-AF82-B4DFCAAD2C89 Q39350215-C560A859-54E4-4038-89EF-98BA1A726EA7 Q39790336-E94607FD-3DE6-4B17-B0AB-AD88D19A8232 Q39801574-0B75FB42-0CBB-43EC-8C36-5ACA14B8B8B9

P2860

Belatacept and Long-Term Outcomes in Kidney Transplantation.

http://www.wikidata.org/entity/Q40055241

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Belatacept and Long-Term Outcomes in Kidney Transplantation.

@en

type

label

Belatacept and Long-Term Outcomes in Kidney Transplantation.

@en

prefLabel

Belatacept and Long-Term Outcomes in Kidney Transplantation.

@en

P1433

Q40055241-17308980-0C02-4B5A-A02C-88C1E07B10F2

P1476

Q40055241-EB54F931-E92C-4B0D-8484-2D4E05E5FA82

P2093

Q40055241-302B7648-211B-4C69-A33A-8D28750C06D8

Q40055241-58E5651C-20BC-4F75-8A9D-B0C1A38B7C9C

Q40055241-5BBEC129-33AB-4A2A-991C-EFBCB3EEE2E9

Q40055241-733030F0-9A7D-4C99-8A90-CB4FEED304F1

Q40055241-77E431C5-499D-4042-85F1-9212A3662F81

Q40055241-995A39F5-249A-4BD6-9C98-FF01EC0BB4EF

Q40055241-A1C40EF0-8D8C-4128-BFEC-53E69A6848EB

Q40055241-AF7C9011-7F5E-4FC5-9384-1B6D57784F31

Q40055241-AFC403D3-B749-4DD7-A09C-63CEE664BDF9

Q40055241-B93A10CD-E54A-47F5-9B05-11798B6937E5

P304

Q40055241-EE0B5790-1CAE-4B46-A7B8-D8D52430C06D

P31

Q40055241-1FC696D1-2AD9-45E8-A8C0-FA55D5585E1F

P356

Q40055241-B8105C98-E31F-442E-AE71-605B655FA644

P407

Q40055241-B9E1C28A-3F31-49C9-A549-72522687D1A4

P433

Q40055241-0F16B1A9-0323-4714-9859-E0AD598694A0

P478

Q40055241-2FB0B8EE-7BB0-49C0-917B-9371DF4A4C98

P50

Q40055241-9035ED5D-77E4-4E61-A05B-E221E61AF2C7

P577

Q40055241-AEAA753C-1E28-43A3-B7BD-D04B07B59D76

P698

Q40055241-AF705D76-0032-4BA8-97E0-7D44C98C5DAA

P356

P1433

The New England Journal of Medicine

P1476

Belatacept and Long-Term Outcomes in Kidney Transplantation.

@en

P2093

Christian P Larsen

http://www.w3.org/2001/XMLSchema#string

Flavio Vincenti

http://www.w3.org/2001/XMLSchema#string

Guillermo A Mondragon-Ramirez

http://www.w3.org/2001/XMLSchema#string

Herwig-Ulf Meier-Kriesche

http://www.w3.org/2001/XMLSchema#string

Jatin Kothari

http://www.w3.org/2001/XMLSchema#string

Joseph Grinyo

http://www.w3.org/2001/XMLSchema#string

Kim Rice

http://www.w3.org/2001/XMLSchema#string

Luis Gaite

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Moal

http://www.w3.org/2001/XMLSchema#string

Martin S Polinsky

http://www.w3.org/2001/XMLSchema#string

P304

333-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1506027

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

374

http://www.w3.org/2001/XMLSchema#string

P50

Lionel Rostaing

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26816011

http://www.w3.org/2001/XMLSchema#string